US Atrial Fibrillation Devices Market Size, Share, Trends, Growth Outlook

US Atrial Fibrillation Devices Market Outlook

The US Atrial Fibrillation Devices Market size is valued at around USD XX billion and is projected to grow at a CAGR of 11% during the forecast period 2022-2030. The United States is expected to control the North America Atrial Fibrillation Devices Market during the forecast period.

Some of the key driving factors participating in the growth of the US market growing the occurrence of the condition, advanced technology, the rising demand for minimally invasive systems, and the surge in the aged population. Furthermore, with high competition in Atrial Fibrillation Devices, new key players appear, and existing players hunt to enhance their market share and product offerings.

Report Key Highlights:

• The US Atrial Fibrillation Devices Market contributes its utmost share to the growth of the North American region.
• Increasing geriatric population is driving the growth of the Atrial Fibrillation Devices Market in the United States
• Growing need for home healthcare equipment is one of the key factors boosting the enhancement of the market
• By Product, the EP ablation catheters segment is expected to register the highest revenue during the forecast period

Outlook

According to the report Application segment, Cardiac Monitors are projected to register the highest share of the market over the forecast period 2022-2030.US Atrial Fibrillation Devices Market companies include Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Johnson & Johnson, and AtriCure, Inc. These major players deliver an inclusive range of devices, from basic hand devices to advanced technological surgical devices, and frequently offer support and training for dental specialists.

Latest Trends:

1. according to an news release made by the company, Atrionix, Inc has been acquired by Johnson & Johnson.
2. As per the press release, With the acquisition in the catheter-based electrophysiology market, Abbott has broadened its medical device business.

US Atrial Fibrillation Devices Market Segmentation:

By Product:

• EP Ablation Catheters
• EP Diagnostic Catheters
• Mapping and Recording Systems
• Cardiac Monitors or Implantable Loop Recorder
• Access Devices
• Intracardiac Echocardiography (ICE)
• Left Atrial Appendage (LAA) Closure Devices

By End-use:

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Others

Major companies in Atrial Fibrillation Devices Covered, globally;

• Atricure Inc
• Microport Scientific Corporation
• Boston Scientific Corporation
• St. Jude Medical, Inc
• Medtronic Plc
• Koninklijke Philips N.V.
• Siemens AG
• Abbott Laboratories
• Johnson & Johnson

US Atrial Fibrillation Devices Market